Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-2-1
pubmed:abstractText
Leukocyte function associated antigen-1 (LFA-1) is a primary cell adhesion molecule of leukocytes required for mediating cellular transmigration into sites of inflammation via the vascular endothelium. A cyclic peptide, cIBR, possesses high affinity for LFA-1, and conjugation to the surface of poly(DL-lactic-co-glycolic acid) nanoparticles can specifically target and deliver the encapsulated agents to T cells expressing LFA-1. The kinetics of targeted nanoparticle uptake by acute lymphoblastic leukemia T cells was investigated by flow cytometry and microscopy and compared to untargeted nanoparticles. The specificity of targeted nanoparticles binding to the LFA-1 integrin was demonstrated by competitive inhibition using free cIBR peptide or using the I domain of LFA-1 to inhibit the binding of targeted nanoparticles. The uptake of targeted nanoparticles was concentration and energy dependent. The cIBR-conjugated nanoparticles did not appear to localize with lysosomes whereas untargeted nanoparticles were detected in lysosomes in 6 h and steadily accumulated in lysosomes for 24 h. Finally, T-cell adhesion to epithelial cells was inhibited by cIBR nanoparticles. Thus, nanoparticles displaying the cIBR ligand may offer a useful targeted drug delivery system as an alternative treatment of inflammatory diseases involving transmigration of leukocytes.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/P20 RR015563-060017, http://linkedlifedata.com/resource/pubmed/grant/P20 RR015563-076485, http://linkedlifedata.com/resource/pubmed/grant/P20 RR015563-086731, http://linkedlifedata.com/resource/pubmed/grant/P20 RR016443, http://linkedlifedata.com/resource/pubmed/grant/P20 RR016443-086923, http://linkedlifedata.com/resource/pubmed/grant/P20 RR016443-096682, http://linkedlifedata.com/resource/pubmed/grant/P20 RR016443-105872, http://linkedlifedata.com/resource/pubmed/grant/R01 AI063002-01A1, http://linkedlifedata.com/resource/pubmed/grant/R01 AI063002-02, http://linkedlifedata.com/resource/pubmed/grant/R01 AI063002-03, http://linkedlifedata.com/resource/pubmed/grant/R01 AI063002-04, http://linkedlifedata.com/resource/pubmed/grant/R03 AR054035, http://linkedlifedata.com/resource/pubmed/grant/R03 AR054035-01A1, http://linkedlifedata.com/resource/pubmed/grant/R03 AR054035-02, http://linkedlifedata.com/resource/pubmed/grant/R03 AR054035-03, http://linkedlifedata.com/resource/pubmed/grant/T32 GM08359-11
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-10507489, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-10553036, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-10613446, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-10861083, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-11035201, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-11544294, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-11606914, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-11857637, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-12020219, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-12234370, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-12636159, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-14620502, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-14733906, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-15319185, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-16207819, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-16305394, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-16923022, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-17680719, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-19429421, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-3517218, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-3911593, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-7680658, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-8658886, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-8856611, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-8871677, http://linkedlifedata.com/resource/pubmed/commentcorrection/19883077-9278346
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1543-8392
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
146-55
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed-meshheading:19883077-Biological Transport, Active, pubmed-meshheading:19883077-Cell Adhesion, pubmed-meshheading:19883077-Cell Aggregation, pubmed-meshheading:19883077-Cell Line, Tumor, pubmed-meshheading:19883077-Drug Delivery Systems, pubmed-meshheading:19883077-Humans, pubmed-meshheading:19883077-Lactic Acid, pubmed-meshheading:19883077-Ligands, pubmed-meshheading:19883077-Lymphocyte Function-Associated Antigen-1, pubmed-meshheading:19883077-Lysosomes, pubmed-meshheading:19883077-Microscopy, Fluorescence, pubmed-meshheading:19883077-Nanoparticles, pubmed-meshheading:19883077-Peptides, Cyclic, pubmed-meshheading:19883077-Polyglycolic Acid, pubmed-meshheading:19883077-Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:19883077-T-Lymphocytes, pubmed-meshheading:19883077-Temperature
pubmed:year
2010
pubmed:articleTitle
cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells.
pubmed:affiliation
Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, Kansas 66047, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural